Navigation Links
It's Safe to Play on Desso Synthetic Turf
Date:5/26/2008

l turnover of more than $ 300 million US dollars.

-- One of the cornerstones of the Desso corporate strategy is sustainability and corporate responsibility. Desso recently signed a partnership with Michael Braungart, who together with William McDonough is known for his Cradle to Cradle principles.

About the German DIN Standard

DIN, the German Institute for Standardization, develops norms and standards as a service to industry, the state and society as a whole. DIN is a registered association (e.V.), with headquarters in Berlin and was founded in 1917. Since 1975, it has been recognized by the German government as the national standards body and represents German interests in European and international standards organizations.

http://www.din.de

For more information:

Desso Sports Systems

http://www.dessosports.com

http://www.surfacesolutionsna.com

http://www.desso.com


'/>"/>
SOURCE Desso Sports Systems
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Experts Agree There is No Scientific Evidence of Health Risks in New Jersey Synthetic Turf Fields
2. Oregon study raises questions on synthetic progestins
3. Synthetic peptoids hold forth promise for new antibiotics
4. New understanding of how big molecules bind will lead to better drugs, synthetic organic materials
5. Collagen Matrix, Inc. Receives FDA 510(k) Clearance for SynOss(TM) Synthetic Mineral Bone Graft Material
6. Varian, Inc. Offers New Products for the Rapid Purification of Synthetic Oligonucleotides.
7. Duramed Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) at North American Menopause Society Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Minneapolis Hosts National Conference on Tobacco or Health October 24-26 on Heels of Minnesota's Statewide, Smoke-Free Law 2Health News:Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 3Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4Health News:Hundreds to Gather for Rally in Celebration of Right to Breathe Clean Air 2Health News:Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines 2Health News:Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines 3Health News:Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines 4Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 2Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 3Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 4
Other Medicine Technology:Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 2Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 3Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 4Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 5Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 6Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 7Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 8Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 9Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 2Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 3Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 4Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 5